The authors concluded that, although oral HRT had a significant beneficial effect on most components of MetS, it could adversely affect c-reactive protein (CRP) and TG concentrations, possibly weakening the beneficial effects of HRT on the cardiovascular system [87]. The gene discussed is CRP; the disease is metabolic syndrome.